APA

Mir R., Ah I., Javid J., Zuberi M., Guru S., Mirza M., Farooq S., Yadav P., Ray P. C., Gupta N. & Saxena A. (2015). Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. : World journal of oncology.

Chicago

Mir Rashid, Ah Imtiyaz, Javid Jamsheed, Zuberi Mariyam, Guru Sameer, Mirza Masroor, Farooq Shazia, Yadav Prasant, Ray Prakash C, Gupta Naresh and Saxena Alpana. 2015. Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. : World journal of oncology.

Harvard

Mir R., Ah I., Javid J., Zuberi M., Guru S., Mirza M., Farooq S., Yadav P., Ray P. C., Gupta N. and Saxena A. (2015). Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. : World journal of oncology.

MLA

Mir Rashid, Ah Imtiyaz, Javid Jamsheed, Zuberi Mariyam, Guru Sameer, Mirza Masroor, Farooq Shazia, Yadav Prasant, Ray Prakash C, Gupta Naresh and Saxena Alpana. Polymorphism T81C in H-RAS Oncogene Is Associated With Disease Progression in Imatinib (TKI) Treated Chronic Myeloid Leukemia Patients. : World journal of oncology. 2015.